ILCs were defined as Lineage(Lin)−CD7+CD127−CD56+CD45RO+, a population that was enriched in CRC tissues and exhibited marked antitumor activity with a tumor-resident profile (CD103+CD69+). The gene discussed is CD69; the disease is neoplasm.